The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates

E-ISSN： 1875-5666|13|3|340-351

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.13, Iss.3, 2013-03, pp. : 340-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical value of serum tumor markers CA199, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 265-268

Spandidos Publications

Access to resources Recommend Favorite

Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma

Current Molecular Medicine, Vol. 17, Iss. 10, 2018-05 ,pp. : 689-698

Bentham Science Publishers

Access to resources Recommend Favorite

ZIP4 is a Novel Diagnostic and Prognostic Marker in Human Pancreatic Cancer: A Systemic Comparison Between EUS-FNA and Surgical Specimens

Current Molecular Medicine, Vol. 14, Iss. 3, 2014-03 ,pp. : 309-315

Bentham Science Publishers

Access to resources Recommend Favorite

The Clinical Utility of Basophil Histamine Release

By Nolte Hendrik

Allergy and Asthma Proceedings, Vol. 14, Iss. 4, 1993-07 ,pp. : 251-254

OceanSide Publications, Inc

Access to resources Recommend Favorite

ESR or CRP? A comparison of their clinical utility

By Osei-Bimpong A. Meek J. H. Lewis S. M.

Hematology, Vol. 12, Iss. 4, 2007-08 ,pp. : 353-357

Maney Publishing

Access to resources Recommend Favorite